Synoda Pharmaceuticals has established two technical platforms, namely, polypeptide drug R&D platform and advanced intermediate R&D platform.
Peptide drug R&D platform: The core members of the company have long been committed to the development of polypeptide drug production processes and quality research.
Core technologies: Long peptide R&D technology, cyclic peptide R&D technology, and polypeptide modification technology.
Advanced intermediate R&D platform: The core members of the company have long been committed to serving enterprises in the biomedical field.
Core technology: ADC/PDC linker development technology, advanced intermediate customization development technology.